HEPION PHARMACEUTICALS, INC. Adjustments to Additional Paid in Capital, Stock Split
HEPION PHARMACEUTICALS, INC. (HEPA) reported Adjustments to Additional Paid in Capital, Stock Split of $0 for the 12-month period ending 2023-12-31, per its 10-K filed 2024-04-16.
Discontinued › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalStockSplit · last filed 2024-04-16
- HEPION PHARMACEUTICALS, INC. adjustments to additional paid in capital, stock split for the quarter ending 2023-06-30 was $0.00.
- HEPION PHARMACEUTICALS, INC. adjustments to additional paid in capital, stock split for fiscal 2023 was $0.00.
| Period end | Adjustments to Additional Paid in Capital, Stock Split 3 month | Adjustments to Additional Paid in Capital, Stock Split 12 month |
|---|---|---|
| 2023-12-31 | $0.00 10-K · filed 2024-04-16 | |
| 2023-06-30 | $0.00 10-Q · filed 2023-11-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |